Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Bbcp Declines As Market Sentiment Shifts 20260403 1 Htgc Stock Analysis Hercules Capital Inc Gains 2.34 Pct To Hit 14.9 Dollar Price Mark 20260403 1 Is Rivernorth Rfm Stock Priced For Growth Price At 13.98 Down 0.64 20260407 Is Blue Moon Bmm Stock Breaking Support Price At 8.39 Up 7.98 20260409 Is Abbvie Abbv Stock In A Buying Zone Price At 206.37 Down 0.15 20260407 ABSI Absci beats Q1 earnings estimates but revenue decline weighs shares rise 26 Wearable WLDS Stock Why It Could Break Out Volatility Increases 20260418 NNBR NN Inc stock gains nearly 14 percent even as it misses Q4 2025 earnings estimates Axos AX Stock High Reward Trade Investor Interest 20260418 Invesco CurrencyShares Euro Trust FXE Top ETF Strategies to Navigate the US Dollars 4Year Low ALRM Alarmcom rises 292 percent on solid Q4 2025 earnings that outpace consensus estimates by 101 percent IRM Iron delivers modest Q4 2025 EPS beat shares tick slightly lower in postearnings trading PXED Phoenix delivers strong Q1 2026 earnings ahead of analyst estimates pushing shares higher in daily trading Albemarle Corporation ALB Downgraded to Neutral Amid Persistent Lithium Market Downturn Risks The valuation case for Accelerant ARX that is hard to ignore Gathers Momentum 20260508 The one number that tells BoH Pref A BOHA whole earnings story Is Motorcar MPAA stock hiding in plain sight On the Radar 20260508 The margin expansion playbook at Geospace GEOS Geospace Posts Loss as Revenue Falls Short BLIN Bridgeline posts narrower than expected Q1 2026 per share loss sending shares up nearly seven percent today Toast TOST Crushes Q1 2026 Estimates EPS 020 Tops Views Feds Rate Path Yardeni Warns of July Hike to Pacify Bond Vigilantes as New Chair Warsh Faces Pressure Transportation Secretary Duffys Reality Show Raises ConflictofInterest Questions Sponsors Include Firms Under His Agencys Watch Cerebras Systems IPO Draws Cramers Caution Amid Massive FirstDay Rally Inner Voyage Recovery Center Expands Access with Virtual Intensive Outpatient Program Launch Goldman Sachs CEO David Solomons Teenage Work Ethic A Message for Gen Z Moderna MRNA Fell 165 Is a Recovery Ahead 20260518 Independent IBCP Q1 2026 Earnings Why the Beat Matters RELX PLC RELX Q2 2025 Results Exceed Forecasts Key Drivers Inside Standard BioTools LAB Q1 2026 Earnings 033 EPS Surges Past 006 Estimates Nasdaq Composite Faces Morning Decline While Dow Shows Relative Resilience Memory Stocks Slide as Seagate CEOs Remarks Stir Market Uncertainty SP 500 Claws Higher as Healthcare and Tech Rally Communication Services Lags Loop Capital Initiates Coverage on American Express with Buy Rating Names Top Pick Indias Labor Market Faces Pressure as Iran Conflict Disrupts Remittances and Trade US Seeks to Expand American AI Integration Across Asia After TrumpXi Engagement Prediction Markets Face Mounting Legal Pressure StateFederal Regulatory Clash Intensifies MainStreet Bancshares Inc MNSB Q1 2026 Earnings EPS Surges Past Estimates with 242 Beat Amplitech Group Inc Series B Right AMPGZ Q1 2026 Earnings EPS Misses Estimates on Wide Surprise Stock Drops Over 18 RRR Q1 2026 Earnings EPS Beat Drives Positive Market Response FHTX Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances INVH Q1 2026 Earnings EPS Surpasses Estimates by 42 Driving Modest Stock Gains Albertsons ACI Declines Nearly 3 as Grocery Sector Faces Headwinds Cisco Systems CSCO Gains 13 as Stock Holds Above Key Support Level Biogen BIIB Trading Flat at 19356 Key Levels in Focus ANSCW Warrants Hold Steady at 023 Amid Low Volatility Jim Cramer Tech Investing Landscape Undergoes Permanent Shift Toward Semiconductor and AI Infrastructure Amazon AMZN and Microsoft Azure Competition Intensifies Evaluating Cloud Market Leaders Fractyl Health Inc GUTS Q1 2026 Earnings EPS Surprise Beats Estimates as Cash Burn Continues Nvidia Reports Strong Revenue Growth Driven by AI Surge but Shares Decline Amid Competitive Concerns Marker Therapeutics Q1 2026 Earnings Loss Narrows as Clinical Progress Continues